05 October 2018

Da Volterra at BIO Europe in Copenhagen

Meet Da Volterra at BIO Europe 2018 in Copenhagen, the Europe’s largest partnering conference serving the global biotechnology industry!

We look forward to sharing updates on DAV132 and meeting with both current and potential partners!

news

11 February 2020

Da Volterra Announces Positive Top-line Results from a Phase 2 Clinical Trial Evaluating DAV132 in 260 Patients

• First clinical study evaluating DAV132 in patients • Primary endpoint met: DAV132 was safe for use in…

events

03 February 2020

Da Volterra’s CEO, Florence Séjourné, is attending BIO CEO in New York on Feb 10-11, 2020!

The BIO CEO & Investor Conference is one of the largest investor conferences focused on established and emerging publicly traded…

events

12 December 2019

Da Volterra’s CEO, Florence Séjourné, and CBO, Pierre-Alain Bandinelli, are attending J.P. Morgan Healthcare Conference in SFO!

The annual J.P. Morgan Healthcare Conference is the largest and most informative healthcare investment symposium in the industry, bringing together…